ArticleScientific reports2021
An efficient context-aware screening system for Alzheimer's disease based on neuropsychology test.
Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep learning-based speech analysis for Alzheimer's disease detection: a literature review.Alzheimer's research & therapy · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) and other dementias have become the fifth leading cause of death worldwide. Accurate early detection of the disease and its precursor, Mild Cognitive Impairment (MCI), is crucial to alleviate the burden on the healthcare system. While most of the existing work in the literature applied neural networks directly together with several data pre-processing techniques, we proposed in this paper a screening system that is to perform classification based on automatic processing of the transcripts of speeches from the subjects undertaking a neuropsychological test. Our system is also shown applicable to different datasets and languages, suggesting that our system holds a high potential to be deployed widely in hospitals across regions. We conducted comprehensive experiments on two different languages datasets, the Pitt dataset and the NTUHV dataset, to validate our study. The results showed that our proposed system significantly outperformed the previous works on both datasets, with the score of the area under the receiver operating characteristic curve (AUROC) of classifying AD and healthy control (HC) being as high as 0.92 on the Pitt dataset and 0.97 on the NTUHV dataset. The performance on classifying MCI and HC remained promising, with the AUROC being 0.83 on the Pitt dataset and 0.88 on the NTUHV dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.